Partner
CurrentRepresenting serial entrepreneurs, start-ups, research institutions, investors, and public and private companies throughout the U.S., Canada, Europe and Asia with strategic patent portfolio development and patent diligence for over twenty-five years, including Nobel laureates in cancer immunotherapy and nucleic acid therapeutics. Patented a Nobel prize-winning immune checkpoint inhibitor for a university client; implementing innovative patent strategies for several rapidly emerging cell therapy, 3D bioprinting and AI clients; managing the worldwide patent portfolio for a US$3b commercial antibody for a multinational biotech client; working closely and attentively with dozens of companies and their investors on patenting a wide variety of biologicals, pharmaceuticals, digital therapeutics, diagnostics, and mechanical and medical devices.
